Dong Soo Suh

No ORCID on file · 11 papers in corpus · active 2011-2020

Study types

  • article 10
  • letter 1

Condition tags

  • endometriosis 5
  • endometrioma 1
  • adenomyosis 1
article 2020
·doi:10.5468/ogs.20230

OBJECTIVE: The aim of this study was to investigate and compare the dietary patterns of Korean women diagnosed with endometrioma or other benign ovarian cysts. METHODS: A total of 66 patients, comprising 39 patients who were surgically diag…

article 2020

Ossification in non-teratomatous ovaries is extremely rare. This phenomenon may occur in various non-neoplastic or neoplastic ovarian diseases. A 34-year-old woman presented with lower abdominal pain of about 3 months. Transvaginal ultrason…

article 2020
·doi:10.31083/j.ceog.2020.01.4996

Purpose: The aim of this study is to evaluate the association between body mass index (BMI) and endometriosis in Korean women. Materials and Methods: In a hospital-based case-control study, 134 endometriosis cases and 282 ovarian teratoma c…

article 2020

연구배경: Tumor markers are useful for detection and preoperative evaluation of ovarian tumors. We evaluated the clinical usefulness of cancer antigen (CA) 125, human epididymis 4 (HE4), and CA72-4 levels and Risk of Ovarian Malignancy Algorith…

article 2019
Annals of laboratory medicine ·doi:10.3343/alm.2020.40.1.40

BACKGROUND: Tumor markers are useful for detection and preoperative evaluation of ovarian tumors. We evaluated the clinical usefulness of cancer antigen (CA) 125, human epididymis 4 (HE4), and CA72-4 levels and Risk of Ovarian Malignancy Al…

letter 2016
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2015.02.008
article 2015
Acta radiologica (Stockholm, Sweden : 1987) ·doi:10.1177/0284185115609805

BACKGROUND: The classic magnetic resonance imaging (MRI) feature of endometriomas is the shading sign, which is characterized by T2-shortening in ovarian cystic lesions that are hyperintense on T1-weighted images. The shading sign is infreq…

article 2011
·doi:10.5468/kjog.2011.54.12.836

Tamoxifen is a synthetic non-steroid anti-estrogen that has been used effectively for several years in the adjuvant treatment of breast cancer. But, the drug has been associated with development of endometrial poylp, hyperplasia and adenoca…

article 2011
article 2011
article 2011